Global Chorea Treatment Market Size, Status and Forecast 2020-2026

SKU ID :QYR-14375052 | Published Date: 28-Jan-2020 | No. of pages: 129
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Chorea Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Chorea Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medication 1.4.3 Surgery Therapy 1.5 Market by Application 1.5.1 Global Chorea Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Chorea Treatment Market Perspective (2015-2026) 2.2 Chorea Treatment Growth Trends by Regions 2.2.1 Chorea Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Chorea Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Chorea Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Chorea Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Chorea Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Chorea Treatment Players by Market Size 3.1.1 Global Top Chorea Treatment Players by Revenue (2015-2020) 3.1.2 Global Chorea Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Chorea Treatment Market Concentration Ratio 3.2.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2019 3.3 Chorea Treatment Key Players Head office and Area Served 3.4 Key Players Chorea Treatment Product Solution and Service 3.5 Date of Enter into Chorea Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Chorea Treatment Historic Market Size by Type (2015-2020) 4.2 Global Chorea Treatment Forecasted Market Size by Type (2021-2026) 5 Chorea Treatment Breakdown Data by Application (2015-2026) 5.1 Global Chorea Treatment Market Size by Application (2015-2020) 5.2 Global Chorea Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Chorea Treatment Market Size (2015-2020) 6.2 Chorea Treatment Key Players in North America (2019-2020) 6.3 North America Chorea Treatment Market Size by Type (2015-2020) 6.4 North America Chorea Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Chorea Treatment Market Size (2015-2020) 7.2 Chorea Treatment Key Players in Europe (2019-2020) 7.3 Europe Chorea Treatment Market Size by Type (2015-2020) 7.4 Europe Chorea Treatment Market Size by Application (2015-2020) 8 China 8.1 China Chorea Treatment Market Size (2015-2020) 8.2 Chorea Treatment Key Players in China (2019-2020) 8.3 China Chorea Treatment Market Size by Type (2015-2020) 8.4 China Chorea Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Chorea Treatment Market Size (2015-2020) 9.2 Chorea Treatment Key Players in Japan (2019-2020) 9.3 Japan Chorea Treatment Market Size by Type (2015-2020) 9.4 Japan Chorea Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Chorea Treatment Market Size (2015-2020) 10.2 Chorea Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Chorea Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Chorea Treatment Market Size by Application (2015-2020) 11 India 11.1 India Chorea Treatment Market Size (2015-2020) 11.2 Chorea Treatment Key Players in India (2019-2020) 11.3 India Chorea Treatment Market Size by Type (2015-2020) 11.4 India Chorea Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Chorea Treatment Market Size (2015-2020) 12.2 Chorea Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Chorea Treatment Market Size by Type (2015-2020) 12.4 Central & South America Chorea Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Medtronic 13.1.1 Medtronic Company Details 13.1.2 Medtronic Business Overview and Its Total Revenue 13.1.3 Medtronic Chorea Treatment Introduction 13.1.4 Medtronic Revenue in Chorea Treatment Business (2015-2020)) 13.1.5 Medtronic Recent Development 13.2 Boston Scientific 13.2.1 Boston Scientific Company Details 13.2.2 Boston Scientific Business Overview and Its Total Revenue 13.2.3 Boston Scientific Chorea Treatment Introduction 13.2.4 Boston Scientific Revenue in Chorea Treatment Business (2015-2020) 13.2.5 Boston Scientific Recent Development 13.3 Aleva Neurotherapeutics 13.3.1 Aleva Neurotherapeutics Company Details 13.3.2 Aleva Neurotherapeutics Business Overview and Its Total Revenue 13.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction 13.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2015-2020) 13.3.5 Aleva Neurotherapeutics Recent Development 13.4 Teva Pharmaceutical 13.4.1 Teva Pharmaceutical Company Details 13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.4.3 Teva Pharmaceutical Chorea Treatment Introduction 13.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2015-2020) 13.4.5 Teva Pharmaceutical Recent Development 13.5 Pfizer 13.5.1 Pfizer Company Details 13.5.2 Pfizer Business Overview and Its Total Revenue 13.5.3 Pfizer Chorea Treatment Introduction 13.5.4 Pfizer Revenue in Chorea Treatment Business (2015-2020) 13.5.5 Pfizer Recent Development 13.6 GlaxoSmithKline 13.6.1 GlaxoSmithKline Company Details 13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.6.3 GlaxoSmithKline Chorea Treatment Introduction 13.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2015-2020) 13.6.5 GlaxoSmithKline Recent Development 13.7 Bausch Health Companies 13.7.1 Bausch Health Companies Company Details 13.7.2 Bausch Health Companies Business Overview and Its Total Revenue 13.7.3 Bausch Health Companies Chorea Treatment Introduction 13.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2015-2020) 13.7.5 Bausch Health Companies Recent Development 13.8 LivaNova 13.8.1 LivaNova Company Details 13.8.2 LivaNova Business Overview and Its Total Revenue 13.8.3 LivaNova Chorea Treatment Introduction 13.8.4 LivaNova Revenue in Chorea Treatment Business (2015-2020) 13.8.5 LivaNova Recent Development 13.9 Lundbeck 13.9.1 Lundbeck Company Details 13.9.2 Lundbeck Business Overview and Its Total Revenue 13.9.3 Lundbeck Chorea Treatment Introduction 13.9.4 Lundbeck Revenue in Chorea Treatment Business (2015-2020) 13.9.5 Lundbeck Recent Development 13.10 Ipsen 13.10.1 Ipsen Company Details 13.10.2 Ipsen Business Overview and Its Total Revenue 13.10.3 Ipsen Chorea Treatment Introduction 13.10.4 Ipsen Revenue in Chorea Treatment Business (2015-2020) 13.10.5 Ipsen Recent Development 13.11 Alnylam Pharmaceuticals 10.11.1 Alnylam Pharmaceuticals Company Details 10.11.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue 10.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction 10.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) 10.11.5 Alnylam Pharmaceuticals Recent Development 13.12 Prana Biotechnology 10.12.1 Prana Biotechnology Company Details 10.12.2 Prana Biotechnology Business Overview and Its Total Revenue 10.12.3 Prana Biotechnology Chorea Treatment Introduction 10.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2015-2020) 10.12.5 Prana Biotechnology Recent Development 13.13 RespireRx Pharmaceuticals 10.13.1 RespireRx Pharmaceuticals Company Details 10.13.2 RespireRx Pharmaceuticals Business Overview and Its Total Revenue 10.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction 10.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) 10.13.5 RespireRx Pharmaceuticals Recent Development 13.14 Vertex Pharmaceuticals 10.14.1 Vertex Pharmaceuticals Company Details 10.14.2 Vertex Pharmaceuticals Business Overview and Its Total Revenue 10.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction 10.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) 10.14.5 Vertex Pharmaceuticals Recent Development 13.15 SOM Biotech 10.15.1 SOM Biotech Company Details 10.15.2 SOM Biotech Business Overview and Its Total Revenue 10.15.3 SOM Biotech Chorea Treatment Introduction 10.15.4 SOM Biotech Revenue in Chorea Treatment Business (2015-2020) 10.15.5 SOM Biotech Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
List of Tables Table 1. Chorea Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Chorea Treatment Revenue Table 3. Ranking of Global Top Chorea Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Chorea Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medication Table 6. Key Players of Surgery Therapy Table 7. Global Chorea Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Chorea Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Chorea Treatment Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Chorea Treatment Market Share by Regions (2015-2020) Table 11. Global Chorea Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Chorea Treatment Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Chorea Treatment Market Growth Strategy Table 17. Main Points Interviewed from Key Chorea Treatment Players Table 18. Global Chorea Treatment Revenue by Players (2015-2020) (Million US$) Table 19. Global Chorea Treatment Market Share by Players (2015-2020) Table 20. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chorea Treatment as of 2019) Table 21. Global Chorea Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Chorea Treatment Product Solution and Service Table 24. Date of Enter into Chorea Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 27. Global Chorea Treatment Market Size Share by Type (2015-2020) Table 28. Global Chorea Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Chorea Treatment Market Size Share by Application (2015-2020) Table 30. Global Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 31. Global Chorea Treatment Market Size Share by Application (2021-2026) Table 32. North America Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 33. North America Key Players Chorea Treatment Market Share (2019-2020) Table 34. North America Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 35. North America Chorea Treatment Market Share by Type (2015-2020) Table 36. North America Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 37. North America Chorea Treatment Market Share by Application (2015-2020) Table 38. Europe Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Chorea Treatment Market Share (2019-2020) Table 40. Europe Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 41. Europe Chorea Treatment Market Share by Type (2015-2020) Table 42. Europe Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 43. Europe Chorea Treatment Market Share by Application (2015-2020) Table 44. China Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 45. China Key Players Chorea Treatment Market Share (2019-2020) Table 46. China Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 47. China Chorea Treatment Market Share by Type (2015-2020) Table 48. China Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 49. China Chorea Treatment Market Share by Application (2015-2020) Table 50. Japan Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Chorea Treatment Market Share (2019-2020) Table 52. Japan Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 53. Japan Chorea Treatment Market Share by Type (2015-2020) Table 54. Japan Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 55. Japan Chorea Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Chorea Treatment Market Share (2019-2020) Table 58. Southeast Asia Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Chorea Treatment Market Share by Type (2015-2020) Table 60. Southeast Asia Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Chorea Treatment Market Share by Application (2015-2020) Table 62. India Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 63. India Key Players Chorea Treatment Market Share (2019-2020) Table 64. India Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 65. India Chorea Treatment Market Share by Type (2015-2020) Table 66. India Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 67. India Chorea Treatment Market Share by Application (2015-2020) Table 68. Central & South America Key Players Chorea Treatment Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Chorea Treatment Market Share (2019-2020) Table 70. Central & South America Chorea Treatment Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Chorea Treatment Market Share by Type (2015-2020) Table 72. Central & South America Chorea Treatment Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Chorea Treatment Market Share by Application (2015-2020) Table 74. Medtronic Company Details Table 75. Medtronic Business Overview Table 76. Medtronic Product Table 77. Medtronic Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 78. Medtronic Recent Development Table 79. Boston Scientific Company Details Table 80. Boston Scientific Business Overview Table 81. Boston Scientific Product Table 82. Boston Scientific Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 83. Boston Scientific Recent Development Table 84. Aleva Neurotherapeutics Company Details Table 85. Aleva Neurotherapeutics Business Overview Table 86. Aleva Neurotherapeutics Product Table 87. Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 88. Aleva Neurotherapeutics Recent Development Table 89. Teva Pharmaceutical Company Details Table 90. Teva Pharmaceutical Business Overview Table 91. Teva Pharmaceutical Product Table 92. Teva Pharmaceutical Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 93. Teva Pharmaceutical Recent Development Table 94. Pfizer Company Details Table 95. Pfizer Business Overview Table 96. Pfizer Product Table 97. Pfizer Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 98. Pfizer Recent Development Table 99. GlaxoSmithKline Company Details Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Product Table 102. GlaxoSmithKline Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 103. GlaxoSmithKline Recent Development Table 104. Bausch Health Companies Company Details Table 105. Bausch Health Companies Business Overview Table 106. Bausch Health Companies Product Table 107. Bausch Health Companies Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 108. Bausch Health Companies Recent Development Table 109. LivaNova Business Overview Table 110. LivaNova Product Table 111. LivaNova Company Details Table 112. LivaNova Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 113. LivaNova Recent Development Table 114. Lundbeck Company Details Table 115. Lundbeck Business Overview Table 116. Lundbeck Product Table 117. Lundbeck Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 118. Lundbeck Recent Development Table 119. Ipsen Company Details Table 120. Ipsen Business Overview Table 121. Ipsen Product Table 122. Ipsen Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 123. Ipsen Recent Development Table 124. Alnylam Pharmaceuticals Company Details Table 125. Alnylam Pharmaceuticals Business Overview Table 126. Alnylam Pharmaceuticals Product Table 127. Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 128. Alnylam Pharmaceuticals Recent Development Table 129. Prana Biotechnology Company Details Table 130. Prana Biotechnology Business Overview Table 131. Prana Biotechnology Product Table 132. Prana Biotechnology Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 133. Prana Biotechnology Recent Development Table 134. RespireRx Pharmaceuticals Company Details Table 135. RespireRx Pharmaceuticals Business Overview Table 136. RespireRx Pharmaceuticals Product Table 137. RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 138. RespireRx Pharmaceuticals Recent Development Table 139. Vertex Pharmaceuticals Company Details Table 140. Vertex Pharmaceuticals Business Overview Table 141. Vertex Pharmaceuticals Product Table 142. Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 143. Vertex Pharmaceuticals Recent Development Table 144. SOM Biotech Company Details Table 145. SOM Biotech Business Overview Table 146. SOM Biotech Product Table 147. SOM Biotech Revenue in Chorea Treatment Business (2015-2020) (Million US$) Table 148. SOM Biotech Recent Development Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Global Chorea Treatment Market Share by Type: 2020 VS 2026 Figure 2. Medication Features Figure 3. Surgery Therapy Features Figure 4. Global Chorea Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Chorea Treatment Report Years Considered Figure 9. Global Chorea Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Chorea Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Chorea Treatment Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Chorea Treatment Market Share by Players in 2019 Figure 14. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chorea Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Chorea Treatment Revenue in 2019 Figure 16. North America Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Chorea Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Medtronic Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 25. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Boston Scientific Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 27. Aleva Neurotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Aleva Neurotherapeutics Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 29. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Teva Pharmaceutical Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Pfizer Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. GlaxoSmithKline Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 35. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Bausch Health Companies Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 37. LivaNova Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. LivaNova Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 39. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Lundbeck Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 41. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Ipsen Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 43. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Alnylam Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 45. Prana Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Prana Biotechnology Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 47. RespireRx Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. RespireRx Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 49. Vertex Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Vertex Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 51. SOM Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. SOM Biotech Revenue Growth Rate in Chorea Treatment Business (2015-2020) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed
Medtronic Boston Scientific Aleva Neurotherapeutics Teva Pharmaceutical Pfizer GlaxoSmithKline Bausch Health Companies LivaNova Lundbeck Ipsen Alnylam Pharmaceuticals Prana Biotechnology RespireRx Pharmaceuticals Vertex Pharmaceuticals SOM Biotech
  • PRICE
  • $3900
    $7800

Our Clients